TrialBMC musculoskeletal disorders2019

Prognostic ability of the German version of the STarT Back tool: analysis of 12-month follow-up data from a randomized controlled trial.

Sven Karstens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.